Cargando…

In Reply: Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery

Detalles Bibliográficos
Autores principales:	De Witt Hamer, Philip C, Klein, Martin, Hervey-Jumper, Shawn L, Wefel, Jeffrey S, Berger, Mitchel S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	CORRESPONDENCE
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364820/ https://www.ncbi.nlm.nih.gov/pubmed/34131734 http://dx.doi.org/10.1093/neuros/nyab218

Ejemplares similares

Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery
por: De Witt Hamer, Philip C, et al.
Publicado: (2021)

Editorial: Quality of care of glioma patients
por: Forster, Marie-Therese, et al.
Publicado: (2022)

Corrigendum: Editorial: Quality of care of glioma patients
por: Forster, Marie-Therese, et al.
Publicado: (2022)

Involvement of White Matter Language Tracts in Glioma: Clinical Implications, Operative Management, and Functional Recovery After Injury
por: Aabedi, Alexander A., et al.
Publicado: (2022)

5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches
por: Kiesel, Barbara, et al.
Publicado: (2021)

Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
por: Hosmann, Arthur, et al.
Publicado: (2021)

The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers
por: Mischkulnig, Mario, et al.
Publicado: (2022)

TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas
por: Mischkulnig, Mario, et al.
Publicado: (2020)

Cognition and resective surgery for diffuse infiltrative glioma: an overview
por: Klein, Martin, et al.
Publicado: (2012)

Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas
por: Mischkulnig, Mario, et al.
Publicado: (2021)

Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature
por: Morshed, Ramin A., et al.
Publicado: (2021)

5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers
por: Hosmann, Arthur, et al.
Publicado: (2021)

Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis
por: Zhang, John J Y, et al.
Publicado: (2020)

Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology
por: Pekmezci, Melike, et al.
Publicado: (2021)

State-of-the-art imaging for glioma surgery
por: Verburg, Niels, et al.
Publicado: (2020)

Reply to “Comment on: Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study”
por: Bundred, Nigel, et al.
Publicado: (2021)

Sarcopenia Diagnosed Using Masseter Muscle Diameter as a Survival Correlate in Elderly Patients with Glioblastoma
por: Morshed, Ramin A., et al.
Publicado: (2022)

Reply
por: Patel, Yogin, et al.
Publicado: (2020)

Author reply
por: Graham, Philip
Publicado: (2018)

Author reply
por: Graham, Philip
Publicado: (2018)

Reply to Eisenhut
por: Muenchhoff, Maximilian, et al.
Publicado: (2015)

Author's Reply
por: Hoyt, Brian S, et al.
Publicado: (2014)

Reply to Chopra and Rizvi
por: Gandra, Sumanth, et al.
Publicado: (2019)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

T2 FLAIR Hyperintensity Volume Is Associated With Cognitive Function and Quality of Life in Clinically Stable Patients With Lower Grade Gliomas
por: Luks, Tracy L., et al.
Publicado: (2022)

Reply to Hemmige and David
por: Klein, Eili Y, et al.
Publicado: (2019)

Bariatric and metabolic surgery during and after the COVID-19 pandemic – Authors' reply
por: Cummings, David E, et al.
Publicado: (2020)

Prioritising immunisation across the life course – Authors' reply
por: Mosser, Jonathan F, et al.
Publicado: (2021)

Surgery during the COVID-19 pandemic – Authors' reply
por: COVIDSurg Collaborative
Publicado: (2020)

Reply to Weinberger
por: Birring, Surinder S., et al.
Publicado: (2023)

Resection Probability Maps for Quality Assessment of Glioma Surgery without Brain Location Bias
por: De Witt Hamer, Philip C., et al.
Publicado: (2013)

Reply to Goyal et al
por: Hsiang, Michelle S., et al.
Publicado: (2015)

SURG-11. Surgery for control of brain metastases after prior checkpoint inhibitor immunotherapy: a single-center series
por: Morshed, Ramin, et al.
Publicado: (2021)

Health Related Quality of Life in Adult Low and High-Grade Glioma Patients Using the National Institutes of Health Patient Reported Outcomes Measurement Information System (PROMIS) and Neuro-QOL Assessments
por: Gabel, Nicolette, et al.
Publicado: (2019)

Profiling of CSF: Author's Reply
por: Bahn, Sabine, et al.
Publicado: (2006)

High Interobserver Agreement in the Subjective Classification of 5‐Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas
por: Mischkulnig, Mario, et al.
Publicado: (2020)

Reply to M. Swanson et al
por: Jeronimo, Jose, et al.
Publicado: (2017)

Reply
por: Abdelrahman, Tamer, et al.
Publicado: (2015)

Reply
por: Moseley, G. Lorimer, et al.
Publicado: (2015)

Reply
por: Vowles, Kevin E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1n21irk0hu7lv2heanppsi6l0r